Catatonia is a serious mental health condition. People with catatonia might seem unresponsive, not talk, or move in strange ways. It can be linked to other mental health issues or sometimes to brain problems. It requires medical attention.
Every report comes from a Lived member, sent anonymously.
Have you tried Ativan (Lorazepam) for Catatonia?
Catatonia is a syndrome, a recognizable pattern of signs, in which a person's movement, speech and behavior change dramatically. Someone with catatonia may become still and silent for hours or days, stare, hold unusual postures, resist being moved or stop eating and drinking. Less often it takes the opposite form, with purposeless agitation and excitement, or the person repeats other people's words or movements. Catatonia is not a single disease. It appears alongside a wide range of psychiatric, neurological and medical illnesses, and it can affect children as well as adults. Although a person may look unaware, many people know what is happening around them and later remember it, often with intense fear. Catatonia matters because it often responds well to treatment, yet unrecognized immobility and lack of food and fluids can lead to serious medical complications such as pneumonia, blood clots, pressure sores and kidney injury.
Catatonia almost always arises from another condition, and finding that condition is a central part of care. Psychiatric causes include depression, the mania of bipolar disorder, schizophrenia and other psychotic illnesses, autism and psychosis after childbirth. Medical causes are at least as common among people in the hospital for medical or surgical reasons. They include autoimmune encephalitis (brain inflammation caused by the immune system, especially anti-NMDA receptor encephalitis, in which antibodies attack a receptor that nerve cells use to signal to one another), brain infections, lupus, thyroid disease, HIV, head injury and brain tumors. Medicines and drugs can also be responsible, either when a substance such as a corticosteroid or ketamine is taken, or when one is stopped suddenly, such as a benzodiazepine sedative or the antipsychotic clozapine. Autistic people are at particularly high risk. Catatonia is thought to be underrecognized, so the true number of people affected is uncertain.
No single test diagnoses catatonia. A clinician recognizes it by observing and examining the person for characteristic signs, including stupor (little response to the surroundings), mutism, posturing, catalepsy (a limb stays where the examiner places it), resistance to instructions, repetitive movements, grimacing and echoing other people's words or movements. Diagnostic manuals require at least three such signs. Because the person often cannot describe what has happened, accounts from family about recent changes, medicines and substance use are essential. When the picture is unclear, a lorazepam challenge can help. The person receives a small test dose of the sedative lorazepam, and a clear improvement within minutes to half an hour (roughly halving the signs) supports the diagnosis. Further tests look for the underlying cause and for complications. Depending on the situation, these may include blood and urine tests, brain scans (CT or MRI), an EEG (a recording of the brain's electrical activity) to look for seizures, and a lumbar puncture (spinal tap) to test spinal fluid for infection or antibodies. Clinicians also distinguish catatonia from look-alikes such as Parkinson's disease, neuroleptic malignant syndrome and the near-total paralysis of locked-in syndrome. In autistic people, catatonia means a marked change from their usual way of moving and communicating, and in older adults it can be mistaken for a rapidly worsening dementia.
Treatment works on two fronts at once: relieving the catatonia itself and treating whatever is causing it, whether that means treating depression or psychosis, stopping a responsible medicine or giving immune therapy for autoimmune encephalitis. Supportive care prevents complications, for example fluids through a drip or a feeding tube, blood thinners to prevent clots and pressure-relieving mattresses. Treatment usually takes place in a hospital. Benzodiazepines, a family of sedative medicines, are the usual first step, and lorazepam (Ativan) is preferred. Improvement can be dramatic, sometimes within minutes of a dose, though some people need the dose raised over several days, at times well above the amounts used for anxiety. Drowsiness is the main trade-off, and higher doses call for monitoring of breathing. Electroconvulsive therapy (ECT) is the other main treatment and is usually highly effective, including when medicine has not worked. Under general anesthesia, a brief electrical current triggers a controlled seizure; for catatonia, sessions are given at least twice a week. Side effects include confusion for a short time after a session and some memory loss, particularly for personal events around the period of treatment. ECT can also treat underlying severe depression or mania. Antipsychotic medicines need particular care. Catatonia strongly raises the risk of neuroleptic malignant syndrome, a dangerous reaction to these drugs, so they are generally avoided unless a psychotic illness requires them and are withheld when malignant catatonia is suspected. When first-line treatments fail, options with weaker evidence include amantadine and memantine, medicines that act on the brain's glutamate signaling. Most research behind all of these treatments comes from small studies and case reports rather than large trials, although responses are often striking.
With prompt treatment, an acute episode of catatonia can ease quickly. Others improve more slowly or leave some lasting signs, particularly when catatonia occurs within a long-standing psychotic illness. Recovery from the underlying condition, such as encephalitis or severe depression, may take longer than recovery from the catatonia itself. Once catatonia has eased, lorazepam is usually lowered gradually rather than stopped. If signs return during that taper, the care team checks that the underlying illness is fully treated and slows the reduction, and a small number of people need a benzodiazepine longer term. Some people who respond to ECT continue with maintenance sessions. A rare form called periodic catatonia returns in cycles, alternating between stillness and excitement with well periods in between. Because many people remember the episode, it helps when family and staff speak to them directly and explain what is happening throughout, even when they cannot respond.
If someone with autism, depression or a psychotic illness gradually slows down, speaks less or freezes in positions more than usual, raise it with their clinicians, since catatonia is easily missed. A person who becomes still, silent and unresponsive, or stops eating and drinking, needs same-day medical assessment, usually in a hospital. If catatonia signs return while lorazepam is being reduced, contact the care team promptly. Catatonia with a fever, a racing heart or swings in blood pressure can signal malignant catatonia or neuroleptic malignant syndrome, which are life-threatening and need emergency care right away, especially after an antipsychotic has been started or increased.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Catatonia is like, what's helped you, or ask the community a question.